In glioma cells, it was shown that instead of ST6Gal I, ST3Gal IV contributed to the cell migration and survival and overexpression of ST6Gal I could suppress the ST3Gal IV mediated α2,3 sialylation by competing for their common substrates. This evidence concerns the gene ST3GAL4 and central nervous system cancer.